Bibliografía
1. Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.
2. Gutiérrez-Fisac JL, Guallar-Castillón P, León-Muñoz LM, et al. Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: the ENRICA study. Obes Rev. 2012 ;13(4):388–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22151906
3. Frühbeck G. Bariatric and metabolic surgery: a shift in eligibility and success criteria. Nat Rev Endocrinol. 2015;11(8):465–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26055046
4. Catalán V, Gómez-Ambrosi J, Rodríguez A, et al. Adipose tissue immunity and cancer. Front Physiol. 2013;202;4:275. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24106481
5. Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Vol. 542, Nature. Nature Publishing Group; 2017. p. 177–85.
6. Zhang C, Zhang J, Liu Z, et al. More than an Anti-diabetic Bariatric Surgery, Metabolic Surgery Alleviates Systemic and Local Inflammation in Obesity. Obes Surg. 2018;28(11):3658–68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30187424
7. Yarmush ML, D’Alessandro M, Saeidi N. Regulation of Energy Homeostasis After Gastric Bypass Surgery. Annu Rev Biomed Eng. 2017;19(1):459–84.
8. Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106(7):2365–70.
9. Tilg H, Zmora N, Adolph TE, et al. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020 ;20(1):40–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31388093
10. Gómez-Ambrosi J, Moncada R, Valentí V, et al. Cardiometabolic Profile Related to Body Adiposity Identifies Patients Eligible for Bariatric Surgery More Accurately than BMI. Obes Surg. 2015;25(9):1594-1603.
11. Camilleri M, Malhi H, Acosta A. Gastrointestinal Complications of Obesity. Gastroenterology. 2017;152(7):1656–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28192107
12. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med . 2017;376(7):641–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28199805
13. Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27899816
14. Espinet Coll E, López-Nava Breviere G, Nebreda Durán J, et al. Spanish Consensus Document on Bariatric Endoscopy. Part 1. General considerations. Rev Esp Enferm Dig 2018 ;110(6):386–99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29766736
15. Espinet Coll E, López-Nava Breviere G, Nebreda Durán J, et al. Spanish consensus document on bariatric endoscopy. Part 2: specific endoscopic treatments. Rev Esp Enferm Dig 2019 ;111(2):140–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30654612
16. Drucker DJ. Deciphering metabolic messages from the gut drives therapeutic innovation: the 2014 Banting Lecture. Diabetes. 2015;64(2):317–26.
17. Primeaux SD, de Silva T, Tzeng TH, et al. Recent advances in the modification of taste and food preferences following bariatric surgery. Rev Endocr Metab Disord. 2016;17(2):195–207. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27245858
18. Bhandari M, Fobi MAL, Buchwald JN, et al. Standardization of Bariatric Metabolic Procedures: World Consensus Meeting Statement. Obes Surg. 2019;29(Suppl 4):309–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31297742
19. Evers SS, Sandoval DA, Seeley RJ. The Physiology and Molecular Underpinnings of the Effects of Bariatric Surgery on Obesity and Diabetes. Annu Rev Physiol. 2017;79:313–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27912678
20. Mason BL, Wang Q, Zigman JM. The central nervous system sites mediating the orexigenic actions of ghrelin. Annu Rev Physiol. 2014;76:519–33.
21. Frühbeck G, Diez-Caballero A, Gil MJ, et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg. 2004;14(5):606-612
22. Manning S, Batterham RL. The role of gut hormone peptide YY in energy and glucose homeostasis: twelve years on. Annu Rev Physiol. 2014;76:585–608.
23. Stefater MA, Wilson-Pérez HE, Chambers AP, et al. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev. 2012;33(4):595–622. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22550271
24. Olbers T, Björkman S, Lindroos A, et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: A randomized clinical trial. Ann Surg. 2006;244(5):715–22.
25. Gómez-Ambrosi J, Catalán V, Rodríguez A, et al. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care. 2014;37(10):2813–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25011950